International Myeloma Working Group to Honor Dr. Nikhil Munshi, Dr. Shaji Kumar for Exceptional Achievements at 12th Annual IMWG Summit on June 23rd Read more about International Myeloma Working Group to Honor Dr. Nikhil Munshi, Dr. Shaji Kumar for Exceptional Achievements at 12th Annual IMWG Summit on June 23rdAdd new comment
Co-pay Assistance Programs Update (6/7/2021) Read more about Co-pay Assistance Programs Update (6/7/2021)Add new comment
FDA Grants BCMA CAR-T Cilta-cel Priority Review for the Treatment of Relapsed/Refractory Multiple Myeloma Read more about FDA Grants BCMA CAR-T Cilta-cel Priority Review for the Treatment of Relapsed/Refractory Multiple MyelomaAdd new comment
IMF Fundraisers Organize First-Ever Virtual Cooking Class for the Cure Read more about IMF Fundraisers Organize First-Ever Virtual Cooking Class for the CureAdd new comment
IMF Launches Initiative to Improve Outcomes in Multiple Myeloma Among Black Americans - The ASCO Post Read more about IMF Launches Initiative to Improve Outcomes in Multiple Myeloma Among Black Americans - The ASCO PostAdd new comment
With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Read more about With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Add new comment
The International Myeloma Foundation (IMF) Sparks a Season for Change with the Most Impactful Myeloma Action Month Ever Read more about The International Myeloma Foundation (IMF) Sparks a Season for Change with the Most Impactful Myeloma Action Month EverAdd new comment
European Commission (EC) Approves Conditional Marketing Authorization for NEXPOVIO (selinexor) Read more about European Commission (EC) Approves Conditional Marketing Authorization for NEXPOVIO (selinexor)Add new comment
International Myeloma Foundation Says FDA Approval of Bristol Myers Squibb’s and bluebird bio's CAR T-Cell Immunotherapy Treatment for Multiple Myeloma Is Welcome News for Patients Read more about International Myeloma Foundation Says FDA Approval of Bristol Myers Squibb’s and bluebird bio's CAR T-Cell Immunotherapy Treatment for Multiple Myeloma Is Welcome News for PatientsAdd new comment
International Myeloma Foundation Launches “M-Power Charlotte” to Improve Outcomes in Multiple Myeloma, a Cancer That Disproportionately Affects African Americans Read more about International Myeloma Foundation Launches “M-Power Charlotte” to Improve Outcomes in Multiple Myeloma, a Cancer That Disproportionately Affects African AmericansAdd new comment
